I'd like to open a personal account http://www.gohardindaapaint.com/stmap_a1650.html?glyburide.cialis.tadadel.zyrtec best smart drugs 2012 News of the Lazaridis' interest pushed shares in the company a bit higher. The stock turned positive after the news and closed on Thursday up 1.1 percent at $8.20 on the Nasdaq. But it has fallen more than 20 percent since the company warned on its earnings.
